Proshrs Ulsht Nq Bio (BIS) 34.02 $BIS 10 Most R
Post# of 273257
Posted On: 09/03/2016 9:21:14 AM
Proshrs Ulsht Nq Bio (BIS) 34.02 $BIS
10 Most Read ETF Articles of the Week (August 22-26)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 26, 5:42PM CDT
Each day, ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the 10 most read articles of the week on ETF Trends, Aug. 22-26, 2016. Click the...
HYG: 86.90 (+0.40), USO: 10.24 (+0.18), GDXS: 15.57 (-1.13), GDJS: 1.90 (-0.10), XBI: 60.15 (-0.19), BNO: 13.68 (+0.25), IBB: 280.61 (-0.83), ZBIO: 23.89 (+0.17), XLV: 72.65 (+0.08), JNK: 36.64 (+0.20), BIS: 34.02 (+0.19), DUST: 33.55 (-3.89), XLF: 24.57 (+0.11), GDX: 27.35 (+0.93), LABD: 24.34 (+0.23), VHT: 133.16 (+0.19), JDST: 24.76 (-5.16)
Finally A Biotech ETF Bounce?
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jun 01, 7:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have been tempting, even teasing investors with signs the group may be ready to rebound this year only to let market...
BIS: 34.02 (+0.19), FBT: 96.14 (-0.01), XBI: 60.15 (-0.19), IBB: 280.61 (-0.83), LABD: 24.34 (+0.23)
Resisting the Temptation of Biotech ETFs
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 16, 7:00AM CDT
After rallying late in the first quarter and to start the current quarter, it looked liked as though biotechnology stocks and exchange traded funds were shaking the doldrums that have plagued the group dating back to last year. It appears as though...
BIS: 34.02 (+0.19), FBT: 96.14 (-0.01), XBI: 60.15 (-0.19), IBB: 280.61 (-0.83), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
BlackIce Completes the Implementation of Basel II Using the ERA Solution with Vietnam International Bank (VIB)
ACCESSWIRE - Wed Mar 30, 10:19PM CDT
VANCOUVER, BC / ACCESSWIRE / March 30, 2016 / BlackIce Enterprise Risk Management (CSE: BIS) ("BlackIce"
announces the implementation of the Basel II Project utilizing the BlackIce Enterprise Risk Aggregation (ERA™) solution with the Vietnam International Commercial Bank (VIB).
BIS: 34.02 (+0.19)
Two Big Factors Hurting Biotech ETFs
ETFtrends.com - ETF Trends - Tue Oct 06, 3:39PM CDT
Exorbitant drug price concerns and a new Trans-Pacific Partnership deal sent biotech stocks and sector exchange traded funds reeling Tuesday. Biotech sector stocks were among the worst performing areas of the market Tuesday. The iShares Nasdaq...
SBIO: 24.03 (-0.15), BIS: 34.02 (+0.19), FBT: 96.14 (-0.01), PTH: 48.43 (+0.64), IBB: 280.61 (-0.83), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, iShares Nasdaq Biotechnology ETF, ProShares UltraShort Nasdaq Biotechnology ETF, Direxion Daily S&P Biotech Bear 3x Shares and ProShares UltraProShort Nasdaq Biotechnology
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 8:30AM CDT
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, iShares Nasdaq Biotechnology ETF, ProShares UltraShort Nasdaq Biotechnology ETF, Direxion Daily S&P Biotech Bear 3x Shares and ProShares UltraProShort Nasdaq Biotechnology
BIS: 34.02 (+0.19), VRX: 28.76 (-0.36), IBB: 280.61 (-0.83), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
Where Do Biotech ETFs Go From Here?
ETFtrends.com - ETF Trends - Tue Sep 29, 2:49PM CDT
Biotechnology stocks and related exchange traded funds gave back all of their gains this year and then some, and the sector may experience even more pain ahead. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB ) , the largest biotech ETF by...
BIS: 34.02 (+0.19), IBB: 280.61 (-0.83), RXD: 44.08 (-0.02), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
How to Short Biotechnology Stocks with ETFs
Sweta Killa - Zacks Investment Research - Tue Sep 29, 9:17AM CDT
Here are the three ETF ways to play the bearish trend in the biotech sector.
BIS: 34.02 (+0.19), VRX: 28.76 (-0.36), IBB: 280.61 (-0.83), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
Guide to Inverse & Leveraged Biotech ETF Investing
Zacks Equity Research - Zacks Investment Research - Fri Sep 25, 11:08AM CDT
Understanding the basics of investing in the inverse and leveraged biotech ETFs, depending on market conditions.
BIS: 34.02 (+0.19), BIB: 45.81 (-0.22), UBIO: 26.86 (-0.19), LABU: 37.40 (-0.33), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
Clinton Delivers Poison Pill To Biotech ETFs
ETFtrends.com - ETF Trends - Mon Sep 21, 1:27PM CDT
If you’re on team Hillary Clinton in the upcoming presidential election, you might want to trim down exposure to biotechnology stocks and sector-related exchange traded funds. “Price gouging like this in the specialty drug market is...
SBIO: 24.03 (-0.15), BIS: 34.02 (+0.19), BBC: 19.92 (unch), XBI: 60.15 (-0.19), IBB: 280.61 (-0.83), RXD: 44.08 (-0.02), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
This Is The Week! Finally!
Chuck Butler - Daily Reckoning - Mon Sep 14, 9:26AM CDT
This post This Is The Week! Finally! appeared first on Daily Reckoning . The week is finally here when the FOMC will make a rate decision. Chuck Butler remains steadfast in his call - read on to see if the markets are on board too... The post ...
BIS: 34.02 (+0.19), IP: 49.12 (+0.41)
Impressive Bull Run in Biotech ETFs Causes Some to Take Pause
ETFtrends.com - ETF Trends - Thu Jul 16, 10:00AM CDT
The biotechnology sector and related exchange traded funds are breaking out to new highs, but the rapid ascension has some worried about valuations. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB ) , the largest biotech ETF by assets, has...
BIS: 34.02 (+0.19), BIB: 45.81 (-0.22), IBB: 280.61 (-0.83), RXD: 44.08 (-0.02), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
What The ECB Will Do
Chuck Butler - Daily Reckoning - Tue Jun 30, 9:35AM CDT
This post What The ECB Will Do appeared first on Daily Reckoning . Chuck Butler explains the breakdown of the Greek referendum vote that will take place this Sunday, plus the euro rallies then sells off, and another week data print from New...
BIS: 34.02 (+0.19)
Volatility in Healthcare ETFs Ahead of Supreme Court’s Obamacare Ruling
ETFtrends.com - ETF Trends - Mon Jun 15, 2:05PM CDT
The Supreme Court will give its ruling on the a key component in Obamacare that could set off short-term selling in the healthcare stocks and sector-related exchange traded funds at the end of the month. The healthcare sector has been among the...
BIS: 34.02 (+0.19), IYH: 150.80 (+0.24), FHLC: 34.54 (+0.03), RXD: 44.08 (-0.02), LABD: 24.34 (+0.23), VHT: 133.16 (+0.19), XLV: 72.65 (+0.08)
Why I'm Shorting Biotech
George Budwell, The Motley Fool - Motley Fool - Sat Jun 13, 12:16PM CDT
Biotech and biopharma have had an incredible run over the past few years. And like many investors, I've been able to crush the broader markets simply by buying and holding top names in the industry like AbbVie , Gilead Sciences , and Isis...
ESRX: 72.54 (+0.32), BIS: 34.02 (+0.19), ISIS: 57.56 (-0.28), GILD: 76.89 (-0.53), MRK: 62.98 (+0.08), IBB: 280.61 (-0.83), ABBV: 64.12 (+0.09), BMY: 56.35 (-0.41), CELG: 105.49 (-0.88)
10 Most Read ETF Articles of the Week (August 22-26)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Aug 26, 5:42PM CDT
Each day, ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the 10 most read articles of the week on ETF Trends, Aug. 22-26, 2016. Click the...
HYG: 86.90 (+0.40), USO: 10.24 (+0.18), GDXS: 15.57 (-1.13), GDJS: 1.90 (-0.10), XBI: 60.15 (-0.19), BNO: 13.68 (+0.25), IBB: 280.61 (-0.83), ZBIO: 23.89 (+0.17), XLV: 72.65 (+0.08), JNK: 36.64 (+0.20), BIS: 34.02 (+0.19), DUST: 33.55 (-3.89), XLF: 24.57 (+0.11), GDX: 27.35 (+0.93), LABD: 24.34 (+0.23), VHT: 133.16 (+0.19), JDST: 24.76 (-5.16)
Finally A Biotech ETF Bounce?
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jun 01, 7:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have been tempting, even teasing investors with signs the group may be ready to rebound this year only to let market...
BIS: 34.02 (+0.19), FBT: 96.14 (-0.01), XBI: 60.15 (-0.19), IBB: 280.61 (-0.83), LABD: 24.34 (+0.23)
Resisting the Temptation of Biotech ETFs
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 16, 7:00AM CDT
After rallying late in the first quarter and to start the current quarter, it looked liked as though biotechnology stocks and exchange traded funds were shaking the doldrums that have plagued the group dating back to last year. It appears as though...
BIS: 34.02 (+0.19), FBT: 96.14 (-0.01), XBI: 60.15 (-0.19), IBB: 280.61 (-0.83), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
BlackIce Completes the Implementation of Basel II Using the ERA Solution with Vietnam International Bank (VIB)
ACCESSWIRE - Wed Mar 30, 10:19PM CDT
VANCOUVER, BC / ACCESSWIRE / March 30, 2016 / BlackIce Enterprise Risk Management (CSE: BIS) ("BlackIce"
announces the implementation of the Basel II Project utilizing the BlackIce Enterprise Risk Aggregation (ERA™) solution with the Vietnam International Commercial Bank (VIB). BIS: 34.02 (+0.19)
Two Big Factors Hurting Biotech ETFs
ETFtrends.com - ETF Trends - Tue Oct 06, 3:39PM CDT
Exorbitant drug price concerns and a new Trans-Pacific Partnership deal sent biotech stocks and sector exchange traded funds reeling Tuesday. Biotech sector stocks were among the worst performing areas of the market Tuesday. The iShares Nasdaq...
SBIO: 24.03 (-0.15), BIS: 34.02 (+0.19), FBT: 96.14 (-0.01), PTH: 48.43 (+0.64), IBB: 280.61 (-0.83), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, iShares Nasdaq Biotechnology ETF, ProShares UltraShort Nasdaq Biotechnology ETF, Direxion Daily S&P Biotech Bear 3x Shares and ProShares UltraProShort Nasdaq Biotechnology
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 8:30AM CDT
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, iShares Nasdaq Biotechnology ETF, ProShares UltraShort Nasdaq Biotechnology ETF, Direxion Daily S&P Biotech Bear 3x Shares and ProShares UltraProShort Nasdaq Biotechnology
BIS: 34.02 (+0.19), VRX: 28.76 (-0.36), IBB: 280.61 (-0.83), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
Where Do Biotech ETFs Go From Here?
ETFtrends.com - ETF Trends - Tue Sep 29, 2:49PM CDT
Biotechnology stocks and related exchange traded funds gave back all of their gains this year and then some, and the sector may experience even more pain ahead. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB ) , the largest biotech ETF by...
BIS: 34.02 (+0.19), IBB: 280.61 (-0.83), RXD: 44.08 (-0.02), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
How to Short Biotechnology Stocks with ETFs
Sweta Killa - Zacks Investment Research - Tue Sep 29, 9:17AM CDT
Here are the three ETF ways to play the bearish trend in the biotech sector.
BIS: 34.02 (+0.19), VRX: 28.76 (-0.36), IBB: 280.61 (-0.83), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
Guide to Inverse & Leveraged Biotech ETF Investing
Zacks Equity Research - Zacks Investment Research - Fri Sep 25, 11:08AM CDT
Understanding the basics of investing in the inverse and leveraged biotech ETFs, depending on market conditions.
BIS: 34.02 (+0.19), BIB: 45.81 (-0.22), UBIO: 26.86 (-0.19), LABU: 37.40 (-0.33), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
Clinton Delivers Poison Pill To Biotech ETFs
ETFtrends.com - ETF Trends - Mon Sep 21, 1:27PM CDT
If you’re on team Hillary Clinton in the upcoming presidential election, you might want to trim down exposure to biotechnology stocks and sector-related exchange traded funds. “Price gouging like this in the specialty drug market is...
SBIO: 24.03 (-0.15), BIS: 34.02 (+0.19), BBC: 19.92 (unch), XBI: 60.15 (-0.19), IBB: 280.61 (-0.83), RXD: 44.08 (-0.02), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
This Is The Week! Finally!
Chuck Butler - Daily Reckoning - Mon Sep 14, 9:26AM CDT
This post This Is The Week! Finally! appeared first on Daily Reckoning . The week is finally here when the FOMC will make a rate decision. Chuck Butler remains steadfast in his call - read on to see if the markets are on board too... The post ...
BIS: 34.02 (+0.19), IP: 49.12 (+0.41)
Impressive Bull Run in Biotech ETFs Causes Some to Take Pause
ETFtrends.com - ETF Trends - Thu Jul 16, 10:00AM CDT
The biotechnology sector and related exchange traded funds are breaking out to new highs, but the rapid ascension has some worried about valuations. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB ) , the largest biotech ETF by assets, has...
BIS: 34.02 (+0.19), BIB: 45.81 (-0.22), IBB: 280.61 (-0.83), RXD: 44.08 (-0.02), LABD: 24.34 (+0.23), ZBIO: 23.89 (+0.17)
What The ECB Will Do
Chuck Butler - Daily Reckoning - Tue Jun 30, 9:35AM CDT
This post What The ECB Will Do appeared first on Daily Reckoning . Chuck Butler explains the breakdown of the Greek referendum vote that will take place this Sunday, plus the euro rallies then sells off, and another week data print from New...
BIS: 34.02 (+0.19)
Volatility in Healthcare ETFs Ahead of Supreme Court’s Obamacare Ruling
ETFtrends.com - ETF Trends - Mon Jun 15, 2:05PM CDT
The Supreme Court will give its ruling on the a key component in Obamacare that could set off short-term selling in the healthcare stocks and sector-related exchange traded funds at the end of the month. The healthcare sector has been among the...
BIS: 34.02 (+0.19), IYH: 150.80 (+0.24), FHLC: 34.54 (+0.03), RXD: 44.08 (-0.02), LABD: 24.34 (+0.23), VHT: 133.16 (+0.19), XLV: 72.65 (+0.08)
Why I'm Shorting Biotech
George Budwell, The Motley Fool - Motley Fool - Sat Jun 13, 12:16PM CDT
Biotech and biopharma have had an incredible run over the past few years. And like many investors, I've been able to crush the broader markets simply by buying and holding top names in the industry like AbbVie , Gilead Sciences , and Isis...
ESRX: 72.54 (+0.32), BIS: 34.02 (+0.19), ISIS: 57.56 (-0.28), GILD: 76.89 (-0.53), MRK: 62.98 (+0.08), IBB: 280.61 (-0.83), ABBV: 64.12 (+0.09), BMY: 56.35 (-0.41), CELG: 105.49 (-0.88)
(0)
(0)Scroll down for more posts ▼